Investigating incretin-based therapies as a novel treatment for depression in type 2 diabetes: Findings from the South London Diabetes (SOUL-D) Study

• We study the association between incretin-based therapies and depressive symptoms. • All 1735 patients in the cohort had newly diagnosed type 2 diabetes. • The change in mood from baseline to 1-year follow-up was measured. • Patients prescribed incretin-based therapies improved in mood compared to...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:A pilot randomized controlled trial examining the feasibility, acceptability, and efficacy of Adapted Motivational Interviewing for post-operative bariatric surgery patients. - 2016. - Amsterdam [u.a.]
1. Verfasser: Moulton, C.D. (VerfasserIn)
Weitere Verfasser: Pickup, J.C. (BerichterstatterIn), Amiel, S.A. (BerichterstatterIn), Winkley, K. (BerichterstatterIn), Ismail, K. (BerichterstatterIn)
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2016
Zugriff auf das übergeordnete Werk:A pilot randomized controlled trial examining the feasibility, acceptability, and efficacy of Adapted Motivational Interviewing for post-operative bariatric surgery patients
Schlagworte:Type 2 diabetes Depressive symptoms Inflammation Incretin-based therapies
Umfang:4